IN2014KN01026A - - Google Patents

Info

Publication number: IN2014KN01026A
Authority: IN; India
Prior art keywords: formation; inducing; cartilage; capability; bone
Prior art date: 2011-12-05

Application number

Other languages

English (en)

Inventor

Frank Plöger

Florian Wagner

Original Assignee

Bioph Biotech Entw Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-05

Filing date

2012-12-05

Publication date

2015-10-09

2012-12-05 Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh

2015-10-09 Publication of IN2014KN01026A publication Critical patent/IN2014KN01026A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IN1026KON2014 2011-12-05 2012-12-05 IN2014KN01026A (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP11191973.4A EP2602264A1 (de)	2011-12-05	2011-12-05	GDF-5-Mutant zur Induzierung der Knorpelbildung
PCT/EP2012/074549 WO2013083649A1 (en)	2011-12-05	2012-12-05	Gdf-5 mutant for inducing cartilage formation

Publications (1)

Publication Number	Publication Date
IN2014KN01026A true IN2014KN01026A (de)	2015-10-09

Family

ID=47278877

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN1026KON2014 IN2014KN01026A (de)	2011-12-05	2012-12-05

Country Status (23)

Country	Link
US (1)	US9718867B2 (de)
EP (3)	EP2602264A1 (de)
JP (1)	JP6185926B2 (de)
KR (1)	KR102067724B1 (de)
CN (1)	CN104039820B (de)
AU (1)	AU2012347305B2 (de)
BR (1)	BR112014013122A2 (de)
CA (1)	CA2856458C (de)
DK (2)	DK3168230T3 (de)
EA (1)	EA028554B1 (de)
ES (2)	ES2630853T3 (de)
HK (1)	HK1198768A1 (de)
HR (2)	HRP20170205T1 (de)
HU (2)	HUE042191T2 (de)
IN (1)	IN2014KN01026A (de)
LT (2)	LT2788374T (de)
MX (1)	MX351809B (de)
PL (2)	PL3168230T3 (de)
PT (2)	PT3168230T (de)
RS (2)	RS55686B1 (de)
SI (2)	SI2788374T1 (de)
TR (1)	TR201901263T4 (de)
WO (1)	WO2013083649A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101639269B1 (ko)	2015-12-02	2016-07-13	주식회사 셀루메드	알칼라인 포스파타아제 어세이를 개선하기 위한 방법
CN114786707A (zh) *	2019-12-18	2022-07-22	默克专利股份公司	Gdf-5突变体用于治疗疼痛和软骨破坏的用途
CN111701075A (zh) *	2020-06-24	2020-09-25	亘元(天津)生物医药科技有限公司	一种软骨修复材料、软骨重建生物支架及制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2153654A1 (en)	1993-01-12	1994-07-21	Se-Jin Lee	Growth differentiation factor-5
IL110589A0 (en)	1993-08-10	1994-11-11	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF- beta family
WO1995016035A2 (en)	1993-12-07	1995-06-15	Genetics Institute, Inc.	Bmp-12, bmp-13 and tendon-inducing compositions thereof
WO1996014335A1 (en)	1994-11-07	1996-05-17	The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services	Cartilage-derived morphogenetic proteins
DE69636728D1 (de)	1995-04-19	2007-01-04	Bioph Biotech Entw Pharm Gmbh	Neues protein und verfahren zu dessen herstellung
JPH0931098A (ja)	1995-07-24	1997-02-04	Hoechst Japan Ltd	新規なタンパク質ｈｍｗヒトｍｐ５２
ZA966489B (en)	1995-08-03	1997-02-26	Bioph Biotech Entw Pharm Gmbh	New protein human MP52 Arg.
DE19647853A1 (de)	1996-11-19	1998-05-20	Bioph Biotech Entw Pharm Gmbh	Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
JPH11335398A (ja)	1998-05-22	1999-12-07	Hoechst Marion Roussel Kk	新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
EP1074620A1 (de)	1999-08-06	2001-02-07	HyGene AG	Monomer Protein der TGF-beta Familie
JP2000119192A (ja)	1998-10-09	2000-04-25	Aventis Pharma Ltd	骨誘導因子アンタゴニスト活性を有する成熟型蛋白質
DE10026713A1 (de)	2000-05-30	2001-12-06	Walter Sebald	Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
KR100530299B1 (ko)	2003-08-11	2005-11-22	산도즈 게엠베하	변이 세팔로스포린 ｃ 아실라제 및 이를 이용한 7-ａｃａ 제조방법
EP1571159A1 (de)	2004-03-04	2005-09-07	Bayerische Julius-Maximilians-Universität Würzburg	Mutein von Knochenmorphogenetisches Protein und seine Verwendung
EP1698691A1 (de)	2005-03-04	2006-09-06	Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH	Mutanten von Wachstumsfaktoren mit verbesserter biologischer Eigenschaft
EP1721909A1 (de)	2005-05-10	2006-11-15	BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH	Wachstumsfaktoren mit geänderten biologischen Eigenschaften
JP2007054013A (ja)	2005-08-26	2007-03-08	Research Institute Of Innovative Technology For The Earth	耐熱性ｌ−スレオニンアルドラ−ゼおよびそれをコードする遺伝子
PL1948689T3 (pl) *	2005-11-18	2012-09-28	Biopharm Ges Zur Biotechnologischen Entwicklung Von Pharmaka Mbh	Mutanty czynników wzrostu o wysokiej aktywności
CN101443360B (zh)	2006-03-27	2013-11-27	医学免疫有限公司	Gm-csf受体结合元件
EP1915986A1 (de)	2006-10-23	2008-04-30	BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH	Wachstumsfaktorhaltige Lipidformulierungen
KR101800596B1 (ko)	2010-08-20	2017-11-22	와이어쓰 엘엘씨	디자이너 골형성 단백질

2011
- 2011-12-05 EP EP11191973.4A patent/EP2602264A1/de not_active Ceased
2012
- 2012-12-05 US US14/362,691 patent/US9718867B2/en active Active
- 2012-12-05 SI SI201230892A patent/SI2788374T1/sl unknown
- 2012-12-05 RS RS20170146A patent/RS55686B1/sr unknown
- 2012-12-05 RS RS20190038A patent/RS58253B1/sr unknown
- 2012-12-05 HU HUE16203435A patent/HUE042191T2/hu unknown
- 2012-12-05 EP EP12795011.1A patent/EP2788374B1/de active Active
- 2012-12-05 WO PCT/EP2012/074549 patent/WO2013083649A1/en active Application Filing
- 2012-12-05 PL PL16203435T patent/PL3168230T3/pl unknown
- 2012-12-05 IN IN1026KON2014 patent/IN2014KN01026A/en unknown
- 2012-12-05 DK DK16203435.9T patent/DK3168230T3/en active
- 2012-12-05 PT PT16203435T patent/PT3168230T/pt unknown
- 2012-12-05 ES ES12795011.1T patent/ES2630853T3/es active Active
- 2012-12-05 LT LTEP12795011.1T patent/LT2788374T/lt unknown
- 2012-12-05 SI SI201231517T patent/SI3168230T1/sl unknown
- 2012-12-05 KR KR1020147017053A patent/KR102067724B1/ko active IP Right Grant
- 2012-12-05 CN CN201280058254.8A patent/CN104039820B/zh active Active
- 2012-12-05 EA EA201491119A patent/EA028554B1/ru not_active IP Right Cessation
- 2012-12-05 EP EP16203435.9A patent/EP3168230B1/de active Active
- 2012-12-05 DK DK12795011.1T patent/DK2788374T3/en active
- 2012-12-05 MX MX2014006465A patent/MX351809B/es active IP Right Grant
- 2012-12-05 JP JP2014543942A patent/JP6185926B2/ja active Active
- 2012-12-05 PL PL12795011T patent/PL2788374T3/pl unknown
- 2012-12-05 AU AU2012347305A patent/AU2012347305B2/en not_active Ceased
- 2012-12-05 TR TR2019/01263T patent/TR201901263T4/tr unknown
- 2012-12-05 CA CA2856458A patent/CA2856458C/en active Active
- 2012-12-05 LT LTEP16203435.9T patent/LT3168230T/lt unknown
- 2012-12-05 PT PT127950111T patent/PT2788374T/pt unknown
- 2012-12-05 BR BR112014013122-8A patent/BR112014013122A2/pt not_active Application Discontinuation
- 2012-12-05 HU HUE12795011A patent/HUE033025T2/en unknown
- 2012-12-05 ES ES16203435T patent/ES2708675T3/es active Active
2014
- 2014-12-04 HK HK14112248.9A patent/HK1198768A1/xx not_active IP Right Cessation
2017
- 2017-02-08 HR HRP20170205TT patent/HRP20170205T1/hr unknown
2019
- 2019-01-23 HR HRP20190160TT patent/HRP20190160T8/hr unknown

Also Published As

Publication number	Publication date
CN104039820B (zh)	2018-01-09
EA201491119A1 (ru)	2014-12-30
RS58253B1 (sr)	2019-03-29
SI2788374T1 (sl)	2017-04-26
HRP20190160T8 (hr)	2020-02-07
WO2013083649A1 (en)	2013-06-13
CA2856458C (en)	2024-03-12
MX2014006465A (es)	2015-03-20
EP2788374A1 (de)	2014-10-15
ES2708675T3 (es)	2019-04-10
DK3168230T3 (en)	2019-01-14
EP2788374B1 (de)	2017-01-04
PL3168230T3 (pl)	2019-06-28
HUE042191T2 (hu)	2019-06-28
KR20140100969A (ko)	2014-08-18
EP3168230A1 (de)	2017-05-17
EP3168230B1 (de)	2018-12-05
TR201901263T4 (tr)	2019-02-21
US9718867B2 (en)	2017-08-01
JP2015504649A (ja)	2015-02-16
KR102067724B1 (ko)	2020-01-17
LT3168230T (lt)	2019-03-12
BR112014013122A2 (pt)	2020-10-27
HRP20190160T1 (hr)	2019-03-22
AU2012347305B2 (en)	2016-11-03
DK2788374T3 (en)	2017-04-10
MX351809B (es)	2017-10-30
EA028554B1 (ru)	2017-11-30
LT2788374T (lt)	2017-02-10
AU2012347305A1 (en)	2014-06-26
HRP20170205T1 (hr)	2017-06-16
CN104039820A (zh)	2014-09-10
RS55686B1 (sr)	2017-07-31
PT3168230T (pt)	2019-01-30
CA2856458A1 (en)	2013-06-13
JP6185926B2 (ja)	2017-08-23
HK1198768A1 (en)	2015-06-05
PL2788374T3 (pl)	2017-08-31
HUE033025T2 (en)	2017-11-28
PT2788374T (pt)	2017-02-15
ES2630853T3 (es)	2017-08-24
US20140369978A1 (en)	2014-12-18
EP2602264A1 (de)	2013-06-12
SI3168230T1 (sl)	2019-03-29

Publication	Publication Date	Title
IN2014DN10386A (de)	2015-08-14
EA201390803A1 (ru)	2013-09-30	Ингибиторы бромодомена и их применение
TN2012000512A1 (en)	2014-04-01	Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
TN2012000465A1 (en)	2014-01-30	Derivatives of 1-amino-2-cyclopropylethylboronic acid
EP2464724A4 (de)	2013-11-20	Zusammensetzungen und verfahren zur implantierung von bearbeitetem fettgewebe und produkten aus bearbeitetem fettgewebe
TN2012000511A1 (en)	2014-04-01	Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
MX343640B (es)	2016-11-15	Promotor de osteogenesis.
BR112014009418A2 (pt)	2017-04-18	macrociclos peptidomiméticos
PH12014502537A1 (en)	2015-01-21	Therapeutic uses of fibroblast growth factor 21 proteins
HRP20150117T1 (en)	2015-03-13	Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
ZA201403596B (en)	2016-01-27	Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
EP2515926A4 (de)	2013-10-09	Zusammensetzungen und verfahren zur behandlung von durch angiogenese verursachten augenerkrankungen
SMT201600147B (it)	2016-07-01	Metodi per migliorare l'espressione di proteine ricombinanti
PH12014501200A1 (en)	2014-09-08	Bacteriophage gene 3 protein compositions and use as amyloid binding agents
EA201170294A1 (ru)	2011-08-30	Способы лечения реперфузионных повреждений
MY163257A (en)	2017-08-30	Humanised anti-cd52 antibodies
SG10201900541QA (en)	2019-02-27	Derivatives of xanthone compounds
PH12016500495A1 (en)	2016-05-23	Compositions for the treatment of hypertension and/or fibrosis
MX2013002121A (es)	2013-04-03	Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
IN2014DN00254A (de)	2015-06-05
IN2014KN01026A (de)	2015-10-09
MX347541B (es)	2017-04-28	Analogos de acido sialico.
EP2637682A4 (de)	2014-05-14	Verfahren und zusammensetzungen mit cyclischen analoga von histatin-5 zur behandlung von wunden
MX2012012744A (es)	2012-12-17	Composiciones y metodos para el diagnostico y tratamiento de tumores.
EA201390759A1 (ru)	2014-03-31	БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА